Inhaled activated protein C protects mice from ventilator-induced lung injury

Critical Care

Volumn 14, Issue 2, 2010, Pages

  Maniatis, Nikolaos A ^a   Letsiou, Eleftheria ^a   Orfanos, Stylianos E ^a   Kardara, Matina ^a   Dimopoulou, Ioanna ^a   Nakos, Georgios ^b   Lekka, Marilena E ^c   Roussos, Charalambos ^a   Armaganidis, Apostolos ^a   Kotanidou, Anastasia ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b UNIVERSITY OF IOANNINA   (Greece)

^c UNIVERSITY OF IOANNINA   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; CYTOSOLIC PHOSPHOLIPASE A2; DIPEPTIDYL CARBOXYPEPTIDASE; DROTRECOGIN; EOSIN; HEMATOXYLIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MYELOPEROXIDASE; SODIUM CHLORIDE; THROMBIN; THROMBIN RECEPTOR; ANTICOAGULANT AGENT; PROTEIN C;

ANALYSIS OF VARIANCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL GAS; ARTICLE; ARTIFICIAL VENTILATION; C57BL 6 MOUSE; COMPETITIVE INHIBITION; CONTROLLED STUDY; DRUG DOSE INCREASE; DRUG EFFECT; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HYPOXEMIA; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LUNG ALVEOLUS EPITHELIUM; LUNG COMPLIANCE; LUNG FUNCTION; LUNG LAVAGE; LUNG PARENCHYMA; MALE; MOLECULAR DYNAMICS; MOUSE; NEUTROPHIL; NEUTROPHIL COUNT; NONHUMAN; POSITIVE END EXPIRATORY PRESSURE; POST HOC ANALYSIS; PRIORITY JOURNAL; PROTECTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TIDAL VOLUME; TRACHEOTOMY; VENTILATOR INDUCED LUNG INJURY; ANIMAL; C57BL MOUSE; DOSE RESPONSE; INHALATIONAL DRUG ADMINISTRATION;

ADMINISTRATION, INHALATION; ANIMALS; ANTICOAGULANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MICE; MICE, INBRED C57BL; PROTEIN C; VENTILATOR-INDUCED LUNG INJURY;

EID: 77950933003     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc8976     Document Type: Article

References (54)

1. Dreyfuss D, Saumon G. Ventilator-induced lung injury lessons from experimental studies. Am J Respir Crit Care Med 1998, 157:294-323.
2. Gattinoni L, Pesenti A. The concept of "baby lung". Intensive Care Med 2005, 31:776-784. 10.1007/s00134-005-2627-z, 15812622.
3. Lionetti V, Recchia FA, Ranieri VM. Overview of ventilator-induced lung injury mechanisms. Curr Opin Crit Care 2005, 11:82-86. 10.1097/00075198-200502000-00013, 15659950.
4. Oeckler RA, Hubmayr RD. Ventilator-associated lung injury: a search for better therapeutic targets. Eur Respir J 2007, 30:1216-1226. 10.1183/09031936.00104907, 18055706.
5. dos Santos CC, Slutsky AS. The contribution of biophysical lung injury to the development of biotrauma. Annu Rev Physiol 2006, 68:585-618. 10.1146/annurev.physiol.68.072304.113443, 16460285.
6. Maniatis NA, Harokopos V, Thanassopoulou A, Oikonomou N, Mersinias V, Witke W, Orfanos SE, Armaganidis A, Roussos C, Kotanidou A, Aidinis V. A critical role for gelsolin in ventilator-induced lung injury. Am J Respir Cell Mol Biol 2009, 41:426-432. 10.1165/rcmb.2008-0144OC, 19202007.
7. Vlahakis NE, Hubmayr RD. Cellular stress failure in ventilator-injured lungs. Am J Respir Crit Care Med 2005, 171:1328-1342. 10.1164/rccm.200408-1036SO, 2718477, 15695492.
8. Maybauer MO, Maybauer DM, Fraser JF, Traber LD, Westphal M, Enkhbaatar P, Cox RA, Huda R, Hawkins HK, Morita N, Murakami K, Mizutani A, Herndon DN, Traber DL. Recombinant human activated protein C improves pulmonary function in ovine acute lung injury resulting from smoke inhalation and sepsis. Crit Care Med 2006, 34:2432-2438. 10.1097/01.CCM.0000230384.61350.FA, 16810106.
9. Le A, Damico R, Damarla M, Boueiz A, Pae HH, Skirball J, Hasan E, Peng X, Chesley A, Crow MT, Reddy SP, Tuder RM, Hassoun PM. Alveolar cell apoptosis is dependent on p38 MAP kinase-mediated activation of xanthine oxidoreductase in ventilator-induced lung injury. J Appl Physiol 2008, 105:1282-1290. 10.1152/japplphysiol.90689.2008, 2576028, 18669934.
10. Damarla M, Hasan E, Boueiz A, Le A, Pae HH, Montouchet C, Kolb T, Simms T, Myers A, Kayyali US, Gaestel M, Peng X, Reddy SP, Damico R, Hassoun PM. Mitogen activated protein kinase activated protein kinase 2 regulates actin polymerization and vascular leak in ventilator associated lung injury. PLoS ONE 2009, 4:e4600. 10.1371/journal.pone.0004600, 2643011, 19240800.
11. Dolinay T, Wu W, Kaminski N, Ifedigbo E, Kaynar AM, Szilasi M, Watkins SC, Ryter SW, Hoetzel A, Choi AM. Mitogen-activated protein kinases regulate susceptibility to ventilator-induced lung injury. PLoS ONE 2008, 3:e1601. 10.1371/journal.pone.0001601, 2223071, 18270588.
12. Li LF, Liao SK, Ko YS, Lee CH, Quinn DA. Hyperoxia increases ventilator-induced lung injury via mitogen-activated protein kinases: a prospective, controlled animal experiment. Crit Care 2007, 11:R25. 10.1186/cc5704, 2151853, 17316425.
13. Amato MB, Barbas CS, Medeiros DM, Schettino Gde P, Lorenzi Filho G, Kairalla RA, Deheinzelin D, Morais C, Fernandes Ede O, Takagaki TY. Beneficial effects of the "open lung approach" with low distending pressures in acute respiratory distress syndrome. A prospective randomized study on mechanical ventilation. Am J Respir Crit Care Med 1995, 152:1835-1846.
14. The Acute Respiratory Distress Syndrome Network Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000, 342:1301-1308. 10.1056/NEJM200005043421801, 10793162, The Acute Respiratory Distress Syndrome Network.
15. Galiatsou E, Kostanti E, Svarna E, Kitsakos A, Koulouras V, Efremidis SC, Nakos G. Prone position augments recruitment and prevents alveolar overinflation in acute lung injury. Am J Respir Crit Care Med 2006, 174:187-197. 10.1164/rccm.200506-899OC, 16645177.
16. Terragni PP, Del Sorbo L, Mascia L, Urbino R, Martin EL, Birocco A, Faggiano C, Quintel M, Gattinoni L, Ranieri VM. Tidal volume lower than 6 ml/kg enhances lung protection: role of extracorporeal carbon dioxide removal. Anesthesiology 2009, 111:826-835. 10.1097/ALN.0b013e3181b764d2, 19741487.
17. Mosnier LO, Griffin JH. Inhibition of staurosporine-induced apoptosis of endothelial cells by activated protein C requires protease activated receptor-1 and endothelial cell protein C receptor. Biochem J 2003, 373:65-70. 10.1042/BJ20030341, 1223481, 12683950.
18. Galley HF, El Sakka NE, Webster NR, Lowes DA, Cuthbertson BH. Activated protein C inhibits chemotaxis and interleukin-6 release by human neutrophils without affecting other neutrophil functions. Br J Anaesth 2008, 100:815-819. 10.1093/bja/aen079, 18424805.
19. Nick JA, Coldren CD, Geraci MW, Poch KR, Fouty BW, O'Brien J, Gruber M, Zarini S, Murphy RC, Kuhn K, Richter D, Kast KR, Abraham E. Recombinant human activated protein C reduces human endotoxin-induced pulmonary inflammation via inhibition of neutrophil chemotaxis. Blood 2004, 104:3878-3885. 10.1182/blood-2004-06-2140, 15339848.
20. Abraham E. Effects of recombinant human activated protein C in human models of endotoxin administration. Proc Am Thorac Soc 2005, 2:243-247. 10.1513/pats.200501-004AC, 2713322, 16222045.
21. Mosnier LO, Zlokovic BV, Griffin JH. The cytoprotective protein C pathway. Blood 2007, 109:3161-3172. 10.1182/blood-2006-09-003004, 17110453.
22. Finigan JH, Boueiz A, Wilkinson E, Damico R, Skirball J, Pae HH, Damarla M, Hasan E, Pearse DB, Reddy SP, Grigoryev DN, Cheadle C, Esmon CT, Garcia JG, Hassoun PM. Activated protein C protects against ventilator-induced pulmonary capillary leak. Am J Physiol Lung Cell Mol Physiol 2009, 296:L1002-1011. 10.1152/ajplung.90555.2008, 2692806, 19363121.
23. Ware LB, Matthay MA, Parsons PE, Thompson BT, Januzzi JL, Eisner MD. Pathogenetic and prognostic significance of altered coagulation and fibrinolysis in acute lung injury/acute respiratory distress syndrome. Crit Care Med 2007, 35:1821-1828. 10.1097/01.CCM.0000221922.08878.49, 2764536, 17667242.
24. De Backer D, Verdant C, Chierego M, Koch M, Gullo A, Vincent JL. Effects of drotrecogin alfa activated on microcirculatory alterations in patients with severe sepsis. Crit Care Med 2006, 34:1918-1924. 10.1097/01.CCM.0000220498.48773.3C, 16715034.
25. Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, Steingrub JS, Garber GE, Helterbrand JD, Ely EW, Fisher CJ. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001, 344:699-709. 10.1056/NEJM200103083441001, 11236773.
26. Ferrer R, Artigas A, Suarez D, Palencia E, Levy MM, Arenzana A, Perez XL, Sirvent JM. Effectiveness of treatments for severe sepsis: a prospective, multicenter, observational study. Am J Respir Crit Care Med 2009, 180:861-866. 10.1164/rccm.200812-1912OC, 19696442.
27. Levy MM, Dellinger RP, Townsend SR, Linde-Zwirble WT, Marshall JC, Bion J, Schorr C, Artigas A, Ramsay G, Beale R, Parker MM, Gerlach H, Reinhart K, Silva E, Harvey M, Regan S, Angus DC. The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis. Intensive Care Med 36:222-231. 10.1007/s00134-009-1738-3, 2826633, 20069275.
28. Nadel S, Goldstein B, Williams MD, Dalton H, Peters M, Macias WL, Abd-Allah SA, Levy H, Angle R, Wang D, Sundin DP, Giroir B. Drotrecogin alfa (activated) in children with severe sepsis: a multicentre phase III randomised controlled trial. Lancet 2007, 369:836-843. 10.1016/S0140-6736(07)60411-5, 17350452.
29. Liu KD, Levitt J, Zhuo H, Kallet RH, Brady S, Steingrub J, Tidswell M, Siegel MD, Soto G, Peterson MW, Chesnutt MS, Phillips C, Weinacker A, Thompson BT, Eisner MD, Matthay MA. Randomized clinical trial of activated protein C for the treatment of acute lung injury. Am J Respir Crit Care Med 2008, 178:618-623. 10.1164/rccm.200803-419OC, 2542435, 18565951.
30. Yasui H, Gabazza EC, Tamaki S, Kobayashi T, Hataji O, Yuda H, Shimizu S, Suzuki K, Adachi Y, Taguchi O. Intratracheal administration of activated protein C inhibits bleomycin-induced lung fibrosis in the mouse. Am J Respir Crit Care Med 2001, 163:1660-1668.
31. Kotanidou A, Loutrari H, Papadomichelakis E, Glynos C, Magkou C, Armaganidis A, Papapetropoulos A, Roussos C, Orfanos SE. Inhaled activated protein C attenuates lung injury induced by aerosolized endotoxin in mice. Vascul Pharmacol 2006, 45:134-140. 10.1016/j.vph.2006.06.016, 16959545.
32. Yuda H, Adachi Y, Taguchi O, Gabazza EC, Hataji O, Fujimoto H, Tamaki S, Nishikubo K, Fukudome K, D'Alessandro-Gabazza CN, Maruyama J, Izumizaki M, Iwase M, Homma I, Inoue R, Kamada H, Hayashi T, Kasper M, Lambrecht BN, Barnes PJ, Suzuki K. Activated protein C inhibits bronchial hyperresponsiveness and Th2 cytokine expression in mice. Blood 2004, 103:2196-2204. 10.1182/blood-2003-06-1980, 14604971.
33. Allen GB, Pavone LA, DiRocco JD, Bates JH, Nieman GF. Pulmonary impedance and alveolar instability during injurious ventilation in rats. J Appl Physiol 2005, 99:723-730. 10.1152/japplphysiol.01339.2004, 15831795.
34. Bates JH, Irvine CG. Measuring lung function in mice: the phenotyping uncertainty principle. J Appl Physiol 2003, 94:1297-1306.
35. Maniatis NA, Brovkovych V, Allen SE, John TA, Shajahan AN, Tiruppathi C, Vogel SM, Skidgel RA, Malik AB, Minshall RD. Novel mechanism of endothelial nitric oxide synthase activation mediated by caveolae internalization in endothelial cells. Circ Res 2006, 99:870-877. 10.1161/01.RES.0000245187.08026.47, 16973909.
36. Atochina EN, Muzykantov VR, Al-Mehdi AB, Danilov SM, Fisher AB. Normoxic lung ischemia/reperfusion accelerates shedding of angiotensin converting enzyme from the pulmonary endothelium. Am J Respir Crit Care Med 1997, 156:1114-1119.
37. Orfanos SE, Armaganidis A, Glynos C, Psevdi E, Kaltsas P, Sarafidou P, Catravas JD, Dafni UG, Langleben D, Roussos C. Pulmonary capillary endothelium-bound angiotensin-converting enzyme activity in acute lung injury. Circulation 2000, 102:2011-2018.
38. Wong SS, Sun NN, Hyde JD, Ruiz L, Meigs E, Herrin BR, Fastje CD, Macdonald SJ, Witten ML. Drotrecogin alfa (activated) prevents smoke-induced increases in pulmonary microvascular permeability and proinflammatory cytokine IL-1beta in rats. Lung 2004, 182:319-330. 10.1007/s00408-004-2512-5, 15765924.
39. Allen GB, Pavone LA, DiRocco JD, Bates JH, Nieman GF. Pulmonary impedance and alveolar instability during injurious ventilation in rats. J Appl Physiol 2005, 99:723-730. 10.1152/japplphysiol.01339.2004, 15831795.
40. Krepinsky J. Mechanical stretch-induced signal transduction in cultured mesangial cells. Methods Mol Biol 2009, 466:205-221.
41. Mehta D, Malik AB. Signaling mechanisms regulating endothelial permeability. Physiol Rev 2006, 86:279-367. 10.1152/physrev.00012.2005, 16371600.
42. Abdulnour RE, Peng X, Finigan JH, Han EJ, Hasan EJ, Birukov KG, Reddy SP, Watkins JE, Kayyali US, Garcia JG, Tuder RM, Hassoun PM. Mechanical stress activates xanthine oxidoreductase through MAP kinase-dependent pathways. Am J Physiol Lung Cell Mol Physiol 2006, 291:L345-353. 10.1152/ajplung.00453.2005, 16632522.
43. Borbiev T, Verin AD, Birukova A, Liu F, Crow MT, Garcia JG. Role of CaM kinase II and ERK activation in thrombin-induced endothelial cell barrier dysfunction. Am J Physiol Lung Cell Mol Physiol 2003, 285:L43-54.
44. Ngiam N, Peltekova V, Engelberts D, Otulakowski G, Post M, Kavanagh BP. Early growth response-1 worsens ventilator-induced lung injury by upregulating prostanoid synthesis. Am J Respir Crit Care Med 2010,
45. Uhlig U, Haitsma JJ, Goldmann T, Poelma DL, Lachmann B, Uhlig S. Ventilation-induced activation of the mitogen-activated protein kinase pathway. Eur Respir J 2002, 20:946-956. 10.1183/09031936.02.01612001, 12412688.
46. Lee HS, Kim HJ, Moon CS, Chong YH, Kang JL. Inhibition of c-Jun NH2-terminal kinase or extracellular signal-regulated kinase improves lung injury. Respir Res 2004, 5:23. 10.1186/1465-9921-5-23, 538282, 15566575.
47. Li LF, Liao SK, Huang CC, Hung MJ, Quinn DA. Serine/threonine kinase-protein kinase B and extracellular signal-regulated kinase regulate ventilator-induced pulmonary fibrosis after bleomycin-induced acute lung injury: a prospective, controlled animal experiment. Crit Care 2008, 12:R103. 10.1186/cc6983, 2575592, 18691424.
48. Hofstra JJ, Haitsma JJ, Juffermans NP, Levi M, Schultz MJ. The role of bronchoalveolar hemostasis in the pathogenesis of acute lung injury. Semin Thromb Hemost 2008, 34:475-484. 10.1055/s-0028-1092878, 18956288.
49. Wang L, Bastarache JA, Wickersham N, Fang X, Matthay MA, Ware LB. Novel role of the human alveolar epithelium in regulating intra-alveolar coagulation. Am J Respir Cell Mol Biol 2007, 36:497-503. 10.1165/rcmb.2005-0425OC, 1899324, 17099142.
50. Ostrowska E, Reiser G. Protease-activated receptor (PAR)-induced interleukin-8 production in airway epithelial cells requires activation of MAP kinases p44/42 and JNK. Biochem Biophys Res Commun 2008, 366:1030-1035. 10.1016/j.bbrc.2007.12.064, 18086557.
51. Nakos G, Kitsiouli E, Hatzidaki E, Koulouras V, Touqui L, Lekka ME. Phospholipases A2 and platelet-activating-factor acetylhydrolase in patients with acute respiratory distress syndrome. Crit Care Med 2005, 33:772-779. 10.1097/01.CCM.0000158519.80090.74, 15818104.
52. Miyahara T, Hamanaka K, Weber DS, Anghelescu M, Frost JR, King JA, Parker JC. Cytosolic phospholipase A2 and arachidonic acid metabolites modulate ventilator-induced permeability increases in isolated mouse lungs. J Appl Physiol 2008, 104:354-362. 10.1152/japplphysiol.00959.2006, 18006865.
53. Mariggio S, Bavec A, Natale E, Zizza P, Salmona M, Corda D, Di Girolamo M. Galpha13 mediates activation of the cytosolic phospholipase A2alpha through fine regulation of ERK phosphorylation. Cell Signal 2006, 18:2200-2208. 10.1016/j.cellsig.2006.05.003, 16806823.
54. Tsangaris I, Lekka ME, Kitsiouli E, Constantopoulos S, Nakos G. Bronchoalveolar lavage alterations during prolonged ventilation of patients without acute lung injury. Eur Respir J 2003, 21:495-501. 10.1183/09031936.03.00037902, 12662008.